Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological response

Neoadjuvant endocrine therapy (NET) has shown efficacy in terms of clinical response and surgical outcome in postmenopausal patients with estrogen receptor-positive / HER2-negative breast cancer (ER+/HER2- BC)...

Source: Cancer Imaging - January 28, 2020 Category: Radiology Authors: Sarah Boughdad, Laurence Champion, Veronique Becette, Pascal Cherel, Emmanuelle Fourme, Jerome Lemonnier, Florence Lerebours and Jean-Louis Alberini Tags: Research article Source Type: research